PUMA BIOTECHNOLOGY, INC. Property, Plant and Equipment
PUMA BIOTECHNOLOGY, INC. (PBYI) had Property, Plant and Equipment of $103.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Net $103.00K.
- 2026-03-31: Property, Plant and Equipment, Net $124.00K.
- 2025-12-31: Property, Plant and Equipment, Net $187.00K.
- 2025-09-30: Property, Plant and Equipment, Net $305.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $103.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $124.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $187.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $305.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $388.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $474.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $515.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $601.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $680.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $757.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $855.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $907.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $977.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.02M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.15M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.28M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.59M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.76M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $1.92M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.28M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.48M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $2.66M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.86M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.08M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.30M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.20M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.43M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.72M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.96M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $4.24M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $4.31M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.32M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.47M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $4.71M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $4.89M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $5.00M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $5.15M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $5.18M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.22M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.22M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.38M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $2.53M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.58M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $2.41M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.16M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $1.91M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.94M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.77M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.68M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $1.62M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.65M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $1.57M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.48M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $1.17M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.23M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.06M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $682.00K 10-K · filed 2013-04-01 | $682.05K 10-K · filed 2012-03-29 |
| 2011-09-30 | $3.03K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |